Newsletter URO ONCO


Dear Prof Shulyak

Welcome to URO ONCO, the EAU educational platform on uro-oncology. URO ONCO is the destination for up-to-date information on developments in the field of urological malignancies. As urology and oncology continue to converge, a multidisciplinary approach and collaboration with other specialists in fields such as medical oncology and radiotherapy is essential. With URO ONCO, you can keep pace with your colleagues with access to research and commentary on the latest clinical trial issues.

New content is added twice a month, to receive regular updates about new content please register for our -alerts.

New Webcasts!

5th International Symposium on Hormonal Treatment of Prostate Cancer (STOP-5)

View the presentations from the recently held Symposium on Hormonal Treatment of Prostate Cancer (STOP-5) held in Prague in October 2014.

The aim of the meeting was to provide practising urologists with new information about state-of-the-art treatments and procedures in order to help them enhance patient care. The STOP-5 symposium was chaired by Professor Tom Keane from Medical University of South Carolina, Charleston, SC, US and included individual sessions focussing on localised, high risk/locally advanced, metastatic disease and castration-resistant prostate cancer. The meeting comprised plenary lectures, clinical case discussions, debate sessions and workshop breakout groups during which the eminent faculty and participants had interactive discussions, exchanging information and clinical experiences.

Presentations from ERUS 2014, Amsterdam, September 17-19, 2014

View presentations of the Scientific highlights from the 11th European Robotic Urology Section of the European Association of Urology.

The EAU Robotic Urology Section (ERUS) represents the latest field in urological surgery, robotics. These presentations discuss the latest developments in techniques and technologies for robotic surgery and demonstrate live surgical procedures for a broad spectrum of urological issues.

New articles within Prostate

Systematic Review and Meta-analysis of Factors Determining Change to Radical Treatment in Active Surveillance for Localized Prostate Cancer

Eur Urol. 2015 Jan 21. [Epub ahead of print]

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Lancet. 2014 Dec 6;384(9959):2027-35.

Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?

J Clin Oncol 2014;32:4066-4072

The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells

J Urol. 2015 Feb;193(2):690-8

New articles within Bladder

ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy

Eur Urol. 2015 Jan 27. [Epub ahead of print]

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Lancet Oncol. 2015 Jan;16(1):76-86.

Fruits, vegetables, and bladder cancer risk: A systematic review and meta-analysis

Cancer Med. 2015 Jan;4(1):136-46

Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology

BJU Int. 2014 Oct 7. [Epub ahead of print]

Made possible by an educational grant from Ferring, Janssen Pharmaceutical and Takeda

This message has been sent to from Elsevier Communications on behalf of Elsevier Healthcare.
If you no longer wish to receive messages of this nature from us in the future, please click here.
Visit the Elsevier Preference Center to manage more of your communication preferences with us.
Copyright © 2015 Elsevier B.V.. All rights reserved. | Elsevier Privacy Policy
Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands. Reg. No. 33158992 – Netherlands. VAT No. NL 005033019B01.